Abstract
Multiple myeloma (MM)-induced bone disease is mortal for most MM patients. Bisphosphonates are first-line treatment for MM-induced bone disease, since it can inhibit osteoclast activity and the resultant bone resorption by suppressing the differentiation of osteoclast precursors into mature osteoclasts, promoting osteoclast apoptosis and disrupting osteoclast function. However, it is still unclear whether bisphosphonates have an anti-tumour effect. In our previous work, a computational model was built to simulate the pathology of MM-induced bone disease. This paper extends this proposed computational model to investigate the efficacy of bisphosphonates treatment and then clear the controversy of this therapy. The extended model is validated through the good agreement between simulation results and experimental data. The simulation results suggest that bisphosphonates indeed have an anti-tumour effect.
| Original language | English |
|---|---|
| Pages (from-to) | 3373-3378 |
| Number of pages | 6 |
| Journal | Bio-Medical materials and engineering |
| Volume | 24 |
| Issue number | 6 |
| Early online date | 16 Sept 2014 |
| DOIs | |
| Publication status | Published - 2014 |